← Back to Search

Procedure

Small Incision Hip Replacement for Total Hip Replacement

N/A
Waitlist Available
Research Sponsored by Rothman Institute Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient has primary diagnosis of non-inflammatory degenerative joint disease.
Patient is a male or non-pregnant female age 18 years or older at the time of study device implantation.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial will compare two types of femoral stems used in hip replacement surgery to see which one has better short-term outcomes.

Who is the study for?
This trial is for adults over 18 needing a first-time hip replacement due to non-inflammatory joint disease. They must be able to follow the study's procedures and have signed consent forms. It's not for those with infections, immune suppression, previous hip replacements needing revision, BMI over 40, or allergies to implant materials.Check my eligibility
What is being tested?
The study compares short-term outcomes of two different femoral stems used in total hip arthroplasty: Fitmore Femoral stem versus M/L Taper Femoral stem. The goal is to see which one works better following surgery.See study design
What are the potential side effects?
While specific side effects are not listed here, typical risks associated with total hip arthroplasty may include pain at the site, infection risk post-surgery, possible reaction to anesthesia, and complications related to the implants.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a non-inflammatory joint condition.
Select...
I am 18 or older and not pregnant.
Select...
I am eligible for a hip replacement without using bone cement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within six weeks post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and within six weeks post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Short term hip function
Secondary outcome measures
Short-Term Pain Levels of direct anterior and anterolateral surgical approaches

Trial Design

2Treatment groups
Active Control
Group I: Total Hip Arthroplasty using Fitmore femoral stemActive Control1 Intervention
Group II: Total Hip Arthroplasty using M/L Taper Femoral stemActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Rothman Institute OrthopaedicsLead Sponsor
121 Previous Clinical Trials
21,578 Total Patients Enrolled

Media Library

Total Hip Arthoplasty (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT01614028 — N/A
Total Hip Replacement Research Study Groups: Total Hip Arthroplasty using Fitmore femoral stem, Total Hip Arthroplasty using M/L Taper Femoral stem
Total Hip Replacement Clinical Trial 2023: Total Hip Arthoplasty Highlights & Side Effects. Trial Name: NCT01614028 — N/A
Total Hip Arthoplasty (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01614028 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem
2024. "Total Hip Arthroplasty Using Small Direct Anterior Incision: The Role of Short Femoral Stem". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01614028.
All > Pennsylvania > New Jersey
~233 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top